A- share Pre-market Announcement Gold Rush: Chairman of Longji Green Energy Proposes to Buy Back Shares at 0.3 billion -0.6 billion Yuan
DATE:  Feb 06 2024

Lizhu Group (000513) Simaglutide Injection was approved for clinical trials.

National Technology (300077) Holding Subsidiary Signed Annual Purchase Contract with Guoxuan Gaoke.

a subsidiary of Huajian Group (600629) signed an engineering survey and design contract with a total contract price of 0.528 billion yuan.

Mingzhi Electric (603728) intends to increase capital to its Vietnamese subsidiary and build new capacity projects for control motors and drive control products.

Wanfeng Aircraft, a subsidiary of Wanfeng Owei (002085), plans to set up a joint venture to promote in-depth cooperation in the field of eVTOL.

the net profit of lithium energy (300014) in 2023 increased by 15%-20%.

Chairman Longji Green Energy (601012) proposed to buy back shares at 0.3 billion -0.6 billion yuan.

WuXi AppTec (603259) has repurchased 0.69 percent of the company's shares for $1 billion.

overpass crane (002523) has sent a letter to the investment and investment of china car to inquire about the joint reorganization of central and local enterprises.

Ningbo Dechang Technology, a subsidiary of Dechang (605555), recently received a notice of project designation for EPS motors from Tier1, the global head of the automotive steering system. The project life cycle is 4-7 years, the total sales amount is expected to be about 0.292 billion yuan, and mass production is expected to start step by step in May 2024.

Quanfeng Automobile (603982) recently received a notice from a well-known new energy auto parts company in China, selecting the company as the supplier of its controller housing. The expected life cycle is 4 years, the total sales amount is estimated to be about 0.189 billion yuan, and it is expected to be gradually mass produced in 2024.

shunxin holdings, the controlling shareholder of shunxin agriculture (000860), plans to spend 0.1 billion to 0.2 billion yuan to increase its shareholding in the company (including 90.0762 million yuan increased from February 2 to 5), with no price range.

some directors and senior executives of xiexin integration (002506) plan to spend 15 million to 24 million yuan to increase their shares in the company, with no price range.

Jiuan Medical (002432) intends to repurchase shares at a price of 0.6 billion to 1.2 billion yuan to maintain the company's value and shareholders' equity and reduce registered capital. The repurchase price does not exceed 45 yuan per share.

Dazu Laser (002008) intends to repurchase shares at a price of 0.5 billion to 1 billion yuan at a price not exceeding 25 yuan per share.

yabao pharmaceutical (600351) plans to adjust the total repurchase fund to 0.3 billion to 0.6 billion yuan (previously 0.15 billion yuan to 0.3 billion yuan), and the repurchase price will not exceed 7.2 yuan/share.

Sha Chaoqun, general manager of Haiguang Information (688041), proposed to buy back shares at 0.3 billion to 0.5 billion yuan.

ye jiyue, the actual controller, controlling shareholder and chairman of the board of directors of three-dimensional shares (603033), proposed to buy back the shares at 0.2 billion to 0.4 billion yuan. shareholder Wu shanguo plans to increase the shares of the company by 0.1 billion to 0.2 billion yuan.

Happy Home (300997) plans to buy back shares at 0.1 billion yuan to 0.2 billion yuan for cancellation at a price not exceeding 18 yuan per share.

rongbai technology (688005) plans to buy back shares at 0.075 billion to 0.15 billion yuan for cancellation at a price not exceeding 52.18 yuan per share.

Follow Yicai Global on

star50stocks

Ticker Name

Percentage Change

Inclusion Date